Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Performer
6100.5000
139.50
(
2.34
%)
NSE
Aug 13, 2025
15:31 PM
32.17% Gain from 52W Low
Volume:
394.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
09 Nov 2023
6100.50
2.34%
DIVI' S LAB
Hold:
Divi's Laboratories Ltd.
by
Geojit BNP Paribas
Target: 3800
Recommendation
Target
Geojit BNP Paribas
Number of FII/FPI investors increased from 922 to 990 in Jun 2025 qtr.
More from Divi's Laboratories Ltd.
Recommended
Market closes higher, Honasa Consumer's net profit beats Forecaster estimates by 45% in Q1
Trendlyne Marketwatch |
13 Aug 2025, 03:55PM
Five stocks to buy from analysts this week - August 12, 2025
The Baseline |
12 Aug 2025, 05:13PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022